Novartis AG ADR sell Barclays PLC
Start price
22.02.25
/
50%
€103.50
Target price
22.02.26
-
Performance (%)
32.85%
End price
23.02.26
€137.50
Summary
This prediction ended on 23.02.26 with a price of €137.50. The SELL prediction by Barclays_PLC for Novartis AG ADR was trending in the completely wrong direction and closed with a performance of 32.85%. A total of €3.87 was paid as dividends for this prediction. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novartis AG ADR | -5.282% | -5.282% | 31.220% |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % |
Comments by Barclays_PLC for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) had its "underweight" rating re-affirmed by analysts at Barclays PLC.
Ratings data for NVS provided by MarketBeat
In the thread Trading Novartis AG ADR
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten